跳至主要内容
临床试验/NCT00998816
NCT00998816撤回3 期

A Multicenter Prospective Randomized Double-blind Placebo Controlled Trial Assessing the Effect of Perioperative Pregabalin on the Incidence of Chronic Post Thoracotomy Pain Syndrome

Queen's University1 个研究点 分布在 1 个国家开始时间: 2012年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
撤回
试验地点
1
主要终点
Incidence of chronic post thoracotomy pain syndrome

研究概览

简要总结

Pregabalin, administered prior to and following lateral thoracotomy surgery will reduce the likelihood of chronic post-thoracotomy pain syndrome (CPTPS).

详细描述

A total of 200 patients scheduled for lateral thoracotomy will be randomly assigned to receive either placebo or 150 mg pregabalin (Lyrica)1 hour prior to surgery, 12 hr after surgery and then every 12 hr for an additional 10 days. While in the hospital, patients will be assessed for pain intensity, satisfaction and side effects. Patients will be re-assessed at 2, 4 and 6 months following surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Elective open thoracotomy for primary thoracic surgery, understanding and provision of written informed consent, ASA class I II or III

排除标准

  • Inability ot adhere to study protocol:
  • intolerance or hypersensitivity to any agents to be used in the study, contraindication to thoracic epidural placement
  • inability to respond to the study questionnaire
  • renal insufficiency(serum creatinine > 1.5 upper limit of normal)
  • Body Mass index > 40
  • planned post-operative ventilation.
  • Confounding procedural factors which might affect validity of data:
  • previous ipsilateral thoracotomy
  • surgery for tumor extending into the chest wall
  • rest pain in proposed surgical area pre-operatively
  • chest tube in situ at time of surgery
  • requirement for second thoracotomy or re-occurrence of disease after surgery *isolated pleuroscopy or pleurodesis procedures.
  • Potential interaction with study medications and patient's current medications:
  • current alcohol or other substance abuse
  • chronic steroid use
  • pre-existing chronic pain requiring chronic analgesic use
  • history of seizure disorder requiring treatment with an anticonvulsant
  • current therapy with thiazolidinedione class oral hypoglycemic agents (eg, Actos, Avandia or Avandamet)
  • history of congestive heart failure
  • major psychiatric disorder
  • any contraindication to use of NSAIDs.
  • Insufficient safety data in the patient population:
  • patients requiring preoperative assistance or assistive device for ambulation, pregnant or breastfeeding
  • weight <50 Kg
  • dizziness while inpatient.

研究组 & 干预措施

Placebo capsules

Placebo Comparator

one placebo capsule will be administered 1 hour before lateral thoracotomy, 12 hours following the thoracotomy and then every 12h BID for 10 days following lateral thoracotomy.

干预措施: Pregabalin (Drug)

pregabalin capsules

Active Comparator

Pregabalin capsules (150mg) will be administered one hour before lateral thoracotomy, 12 hours following the thoracotomy and then every 12 hours (BID) for 10 days following lateral thoracotomy.

干预措施: Pregabalin (Drug)

结局指标

主要结局

Incidence of chronic post thoracotomy pain syndrome

时间窗: 6 months following surgery

次要结局

  • During hospital stay: pain intensity, PEF and FEV1, patient satisfaction, medication side effects. At 2, 4, and 6 months: pain intensity, pain quality (neuropathic versus other), quality of life, pain interference with daily function(During hospital stay and at 2, 4, and 6 months postoperatively)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jorge Zamora

Associate Professor, MD, FRCPC

Queen's University

研究点 (1)

Loading locations...

相似试验

The Effect of Perioperative Pregabalin on the... | 临床试验